+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Murine susceptibility to organophosphorus-induced delayed neuropathy (OPIDN)



Murine susceptibility to organophosphorus-induced delayed neuropathy (OPIDN)



Toxicology and Applied Pharmacology 107(2): 311-324



This study reports that CD-1 strain mice are neuropathologically and biochemically responsive to acute doses of tri-ortho-cresyl phosphate (TOCP). Young (25-30 g) male and female animals were exposed (po) to a single dose of TOCP (580-3480 mg/kg) and sampled for neurotoxic esterase (NTE) activity at 24 and 44 hr postexposure and for neuropathic damage 14 days later. Biochemically, high intragroup variability existed at the lower doses, and at higher levels of TOCP exposure (i.e., greater than or equal to 1160 mg/kg), mean brain NTE inhibition never exceeded 68%. Hen and mouse brain NTE activity, assayed in vitro for sensitivity to inhibition by tolyl saligenin phosphate (TSP), the active neurotoxic metabolite of TOCP, showed similar IC50 values. Histologically, highly variable spinal cord damage was recorded throughout treatment groups and mean damage scores followed a dose-response pattern with no apparent correlation to threshold (i.e., greater than or equal to 65%) inhibition of brain NTE activity. Topographically, axonal degeneration in the mouse spinal cord predominated in the lateral and ventral columns of the upper cervical cord. Unlike the rat, which displays degeneration in the upper cervical cord's dorsal columns (i.e., gracilis fasciculus) in response to TOCP intoxication, treated mice showed minimal damage to this tract. To examine this discrepancy further, ultrastructural morphometric analysis of axon diameters in the cervical cord was performed in control mice and rats. These results indicated that in both species, the largest diameter (greater than or equal to 4 microns) axons are housed in the ventral columns of the cervical spinal cord, suggesting that axon length and diameter may not be the only criteria underlying fiber tract vulnerability in OPIDN.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 040755629

Download citation: RISBibTeXText

PMID: 1994513

DOI: 10.1016/0041-008x(91)90211-v


Related references

Antibodies to neural proteins in organophosphorus-induced delayed neuropathy (OPIDN) and its amelioration. Neurotoxicology and Teratology 30(3): 161-166, 2008

Immunohistochemical study of phosphorylated neurofilaments during the evolution of organophosphorus ester-induced delayed neuropathy (OPIDN). Neurotoxicology 20(6): 971-975, 1999

Immunohistochemical study of phosphorylated neurofilaments during the evolution of organophosphorus ester-induced delayed neuropathy (OPIDN). Neurotoxicology (Little Rock) 20(6): 971-976, 1999

Calpain activity in organophosphorus-induced delayed neuropathy (OPIDN): effects of a phenylalkylamine calcium channel blocker. Annals of the new York Academy of Sciences 679: 325-329, 1993

Neuropathologic effects of phenylmethylsulfonyl fluoride (PMSF)-induced promotion and protection in organophosphorus ester-induced delayed neuropathy (OPIDN) in hens. Neurotoxicology 20(5): 749-759, 1999

Rodent susceptibility to organophosphate induced delayed neuropathy opidn. Abstracts of Papers American Chemical Society 199(1-2): AGRO 83, 1990

The cytoskeleton as a target for organophosphorus ester-induced delayed neurotoxicity (OPIDN). Chemico-Biological Interactions 87(1-3): 383-393, 1993

The role of protein phosphorylation in organophosphorus compound induced delayed neurotoxicity opidn. Journal of Neurochemistry 52(Suppl.): S198, 1989

Studies on the molecular pathogenesis of organophosphorus compound-induced delayed neurotoxicity (OPIDN). Insecticide action: from molecule to organism edited by Toshio Narahashi and ice E Chambers: 216, 1989

The role of neurotoxic esterase (NTE) in the prevention and potentiation of organophosphorus-induced delayed neurotoxicity (OPIDN). Chemico-Biological Interactions 87(1-3): 395-406, 1993

Biochemical evaluation of organophosphorus-ester induced delayed neurotoxicity (OPIDN): the role of 2',3'-cyclic nucleotide 3'-phosphohydrolase. Neurotoxicology 8(1): 211-222, 1987

Neuropathology of organophosphate-induced delayed neuropathy (OPIDN) in young chicks. Archives of Toxicology 68(5): 308-316, 1994

Potentiation of organophosphorus compound-induced delayed neurotoxicity (OPIDN) in the central and peripheral nervous system of the adult hen: distribution of axonal lesions. Journal of Toxicology and Environmental Health 51(6): 571-590, 1997

High-dose intravenous paraoxon exposure does not cause organophosphate-induced delayed neuropathy (OPIDN) in mini pigs. Journal of Applied Toxicology 21(4): 263-268, 2001

Triphenyl phosphite neuropathy differs from organophosphorus-induced delayed neuropathy in rats. Neuropathology and Applied Neurobiology 13(3): 193-208, 1987